Stock search

Ticker or company name

ELV card

ELV price forecast

Elevance Health$446,28

P/E now is 19,0. Average over 5 years: 17,3 (range 16–19). The stock is 10% above its history.

Base · FY2030

$1 020,53+22,2% a year

The base case gives 22,2% a year, above your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$220 bn$242 bn$267 bn$295 bn$325 bn
Net income$7,89 bn$8,71 bn$9,61 bn$10,6 bn$11,7 bn
EPS$36,03$40,75$46,08$52,11$58,94

Changed values are highlighted. Bear and bull cases: growth ∓ 4,3%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $446,28

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$339,51

Price change
−23,9%
A year
−6,4%
Fair value today
$229,26
Margin of safety
−48,6%

Base$1 020,53

Price change
+128,7%
A year
+22,2%
Fair value today
$689,14
Margin of safety
+54,4%

Bull$2 145,99

Price change
+380,9%
A year
+46,4%
Fair value today
$1 449,14
Margin of safety
+224,7%

What growth the price implies

For the stock to return 10% a year, revenue must grow 1,1% a year to FY2030 at a 3,6% margin and P/E 17,3.

Growth over 5 years
10,3%
Analyst consensus
no data
In your model
10,3%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$1 020,53+22,2% a year